Consultation informs strategies to improve functional evidence use in variant classification
Rehan M Villani1, Bronwyn Terrill2,3,4, Emma Tudini1
1QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Medrxiv : the Preprint Server for Health Sciences
|December 16, 2024
Summary
Genetic diagnostic professionals struggle to use experimental assay data for variant classification due to unclear guidelines. Resources and expert recommendations are needed to improve the application of functional evidence in clinical practice.
Area of Science:
- Genetics
- Clinical Diagnostics
- Bioinformatics
Background:
- Variant classification is crucial for diagnosing genetic diseases.
- Experimental assay data offers strong evidence for variant pathogenicity but is underutilized.
- Applied genetics professionals face challenges in integrating functional evidence into clinical practice.
Purpose of the Study:
- To assess the application of functional evidence in variant classification by genetic diagnostic professionals in Australasia.
- To identify barriers and needs for improving the use of experimental assay data in clinical settings.
Main Methods:
- A survey was conducted among genetic diagnostic professionals in Australasia.
- The survey assessed confidence and practices regarding the use of functional evidence.
- Analysis focused on identifying needs for support resources and updated guidelines.
Main Results:
- Survey respondents expressed low confidence in applying functional evidence.
- Uncertainty regarding practice recommendations was a primary barrier.
- Professionals requested educational opportunities, expert recommendations, and updated guidelines.
Conclusions:
- There is a significant need to enhance the utilization of functional evidence in variant classification.
- Developing clear guidelines and providing expert recommendations are essential for improving diagnostic practice.
- A curated list of functional assays from expert panels serves as an initial step towards supporting evidence evaluation.
More Related Videos
Related Concept Videos
Comparing Copy Number Variations and SNPs
17.2K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
17.2K
Genome-wide Association Studies-GWAS
12.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.4K


